ProShare Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | $1.22M | Sell |
|
|||||
|
2024
Q4 | $2.5M | Sell |
|
|||||
|
2024
Q3 | $2.67M | Buy |
|
|||||
|
2024
Q2 | $2.06M | Buy |
|
|||||
|
2024
Q1 | $2.54M | Sell |
|
|||||
|
2023
Q4 | $2.72M | Sell |
|
|||||
|
2023
Q3 | $2.37M | Sell |
|
|||||
|
2023
Q2 | $2.7M | Buy |
|
|||||
|
2023
Q1 | $2.24M | Buy |
|
|||||
|
2022
Q4 | $1.66M | Buy |
|
|||||
|
2022
Q3 | $1.36M | Sell |
|
|||||
|
2022
Q2 | $1.65M | Sell |
|
|||||
|
2022
Q1 | $3.03M | Sell |
|
|||||
|
2021
Q4 | $4.13M | Buy |
|
|||||
|
2021
Q3 | $3.5M | Sell |
|
|||||
|
2021
Q2 | $3.2M | Buy |
|
|||||
|
2021
Q1 | $1.38M | Sell |
|
|||||
|
2020
Q4 | $1.2M | Buy |
|
|||||
|
2020
Q3 | $954K | Buy |
|
|||||
|
2020
Q2 | $711K | Buy |
|
|||||
|
2020
Q1 | $339K | Sell |
|
|||||
|
2019
Q4 | $811K | Buy |
|
|||||
|
2019
Q3 | $639K | Sell |
|
|||||
|
2019
Q2 | $719K | Sell |
|
|||||
|
2019
Q1 | $861K | Buy |
|
|||||
|
2018
Q4 | $521K | Sell |
|
|||||
|
2018
Q3 | $762K | Buy |
|
|||||
|
2018
Q2 | $586K | Buy |
|
|||||
|
2018
Q1 | $557K | Sell |
|
|||||
|
2017
Q4 | $587K | Buy |
|
|||||
|
2017
Q3 | $450K | Sell |
|
|||||
|
2017
Q2 | $434K | Sell |
|
|||||
|
2017
Q1 | $443K | Sell |
|
|||||
|
2016
Q4 | $398K | Buy |
|
|||||
|
2016
Q3 | $364K | Sell |
|
|||||
|
2016
Q2 | $451K | Buy |
|
|||||
|
2016
Q1 | $415K | Sell |
|
|||||
|
2015
Q4 | $486K | Buy |
|
|||||
|
2015
Q3 | $348K | Sell |
|
|||||
|
2015
Q2 | $601K | Sell |
|
|||||
|
2015
Q1 | $699K | Sell |
|
|||||
|
2014
Q4 | $626K | Sell |
|
|||||
|
2014
Q3 | $1.51M | Buy |
|
|||||
|
2014
Q2 | $1.26M | Buy |
|
|||||
|
2014
Q1 | $381K | Sell |
|
|||||
|
2013
Q4 | $1.91M | Buy |
|
|||||
|
2013
Q3 | $260K | Buy |
|